Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Publication of CL2022002490A1publicationCriticalpatent/CL2022002490A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Peptides Or Proteins
(AREA)
Abstract
La presente invención proporciona un compuesto de la fórmula (I) o una sal farmacéuticamente aceptable del mismo; un método de elaboración de dicho compuesto, y sus usos terapéuticos. La presente invención proporciona además una combinación de agentes farmacológicamente activos y una composición farmacéutica que comprende dicho compuesto.The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method of making said compound, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition comprising said compound.
CL2022002490A2020-03-162022-09-12
Biaryl derivatives as inhibitors of yap/taz-tead protein-protein interaction
CL2022002490A1
(en)